"UPMC Western Maryland is a hospital located in Cumberland. Visit our website to learn more about the conditions we treat and the services we offer. Schedule your appointment today. UPMC is committed to protecting our communities from the spread of COVID-19. We continue to require people who come to any UPMC facility to wear a facemask that covers their nose and mouth and to practice other preventative efforts like social distancing, even if fully vaccinated."

During the past decade, UPMC Western Maryland conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 22 clinical trials were completed, i.e. on average, 61.1% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 19 clinical trials were completed. i.e. 135.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UPMC Western Maryland" #1 sponsor was "National Cancer Institute (NCI)" with 18 trials, followed by "SWOG Cancer Research Network" with 18 trials sponsored, "Alliance for Clinical Trials in Oncology" with 4 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored and "Agendia" with 3 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UPMC Western Maryland" #1 collaborator was "National Cancer Institute (NCI)" with 26 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator and "North Central Cancer Treatment Group" with 2 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "UPMC Western Maryland" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Stage IV Lung Cancer AJCC v8" (6 trials), "Stage IVA Lung Cancer AJCC v8" (6 trials) and "Stage IVB Lung Cancer AJCC v8" (6 trials). Many other conditions were trialed in "UPMC Western Maryland" in a lesser frequency.

Most popular intervention types in "UPMC Western Maryland" are "Drug" (39 trials), "Other" (28 trials), "Biological" (23 trials), "Procedure" (8 trials) and "Dietary Supplement" (2 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (16 trials), "Docetaxel" (9 trials), "Nivolumab" (9 trials), "Quality-of-Life Assessment" (8 trials) and "Computed Tomography" (7 trials). Other intervention names were less common.

The vast majority of trials in "UPMC Western Maryland" are 44 trials for "All" genders and 7 trials for "Female" genders.

Currently, there are NaN active trials in "UPMC Western Maryland". undefined are not yet recruiting, 13 are recruiting, 23 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in UPMC Western Maryland, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in UPMC Western Maryland, 0 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".